Sign In
Buy NTRB
$3.11
+0.210 (+7.24%)
At Close: Jun 22, 2026
Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference
07:00am, Friday, 15'th May 2026
Nutriband's Active Intelligence subsidiary to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference Company to Meet with Buyers from Walmart Inc, Walgreens,
Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast
07:00am, Wednesday, 22'nd Apr 2026
ORLANDO, Fla., April 22, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO and Co-Founder, Gareth Sheridan has featured on the latest episode of the Jac
Reviewing electroCore (NASDAQ:ECOR) & Nutriband (NASDAQ:NTRB)
01:00am, Tuesday, 07'th Apr 2026
electroCore (NASDAQ: ECOR - Get Free Report) and Nutriband (NASDAQ: NTRB - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies bas
Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
04:05pm, Monday, 30'th Mar 2026
Nutriband has selected the commercial worldwide brand name for its lead product, an abuse deterrent fentanyl transdermal system, and will submit to the FDA for approval per FDA Guidance. Nutriband par
Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica
07:28am, Tuesday, 17'th Feb 2026
ORLANDO, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) today announced that it has signed an exclusive distribution agreement with Costa Rica Based Innomedica f
Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points
07:00am, Friday, 30'th Jan 2026
ORLANDO, Fla., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) has provided an update to shareholders on the key milestones and discussions from this years Annual Share
Nutriband CEO Publishes Letter to Shareholders
07:00am, Wednesday, 31'st Dec 2025
ORLANDO, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on achie
What's Going On With Nutriband Stock Monday?
04:40pm, Monday, 29'th Dec 2025
Nutriband shares are trading higher Monday after the company it signed an agreement to sell the majority stake of its subsidiary, Pocono Pharmaceutical, to EarthVision Bio.
Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio
09:00am, Monday, 29'th Dec 2025
Earthvision Bio, is currently developing and commercializing its line of sustainable products developed by Dr. Gordon Moore, the founder of Intel, and Dr. Hans Franke, ex-chairman for Chevron Europe N
Prescription pharmaceutical transdermal fentanyl is a valuable treatment for management of pain in opioid-tolerant patients, severe enough to require daily, around-the-clock, long-term opioid treatmen
Head to Head Review: Nutriband (NASDAQ:NTRB) vs. Quoin Pharmaceuticals (NASDAQ:QNRX)
01:56am, Thursday, 04'th Dec 2025
Quoin Pharmaceuticals (NASDAQ: QNRX - Get Free Report) and Nutriband (NASDAQ: NTRB - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two
Nutriband (NTRB) Expected to Announce Quarterly Earnings on Tuesday
01:08am, Tuesday, 25'th Nov 2025
Nutriband (NASDAQ: NTRB - Get Free Report) is projected to announce its results before the market opens on Tuesday, December 2nd. Analysts expect the company to announce earnings of ($2.13) per share
Nutriband Inc. To Present at The 2025 Noble Capital Markets Emerging Growth Equity Conference
07:00am, Monday, 24'th Nov 2025
Orlando, Florida--(Newsfile Corp. - November 24, 2025) - Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), today announced that its Chairman and Co-Founder, Serguei Melnik will present at NobleCon21 - No
REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
11:05am, Tuesday, 28'th Oct 2025
Nutriband met with US FDA to obtain feedback on the Chemistry, Manufacturing, and Controls plans for AVERSA™ FENTANYL (abuse deterrent transdermal system) through commercialization. Nutriband receiv
Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
07:00am, Tuesday, 28'th Oct 2025
Nutriband met with US FDA to obtain feedback on the Chemistry, Manufacturing, and Controls plans for AVERSA™ FENTANYL (abuse deterrent transdermal system) through commercialization. Nutriband receiv
